<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>22</Volume>
      <Issue>6</Issue>
      <PubDate PubStatus="epublish">
        <Year>2023</Year>
        <Month>12</Month>
        <Day>28</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Methyltransferase-like 3 (METTL3) Epigenetically Modulates Glutathione Peroxidase 4 (GPX4) Expression to Affect Asthma</title>
    <FirstPage>551</FirstPage>
    <LastPage>560</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Liangfeng</FirstName>
        <LastName>Lin</LastName>
        <affiliation locale="en_US">Department of Pediatrics, the Second Affiliated Hospital of Fujian Medical University,  Quanzhou, Fujian Province, China</affiliation>
      </Author>
      <Author>
        <FirstName>Xiaohao</FirstName>
        <LastName>Hu</LastName>
        <affiliation locale="en_US">Department of Pediatrics, the Second Affiliated Hospital of Fujian Medical University,  Quanzhou, Fujian Province, China</affiliation>
      </Author>
      <Author>
        <FirstName>Qiaoyu</FirstName>
        <LastName>Li</LastName>
        <affiliation locale="en_US">Department of Pediatrics, the Second Affiliated Hospital of Fujian Medical University,  Quanzhou, Fujian Province, China</affiliation>
      </Author>
      <Author>
        <FirstName>Linlin</FirstName>
        <LastName>Huang</LastName>
        <affiliation locale="en_US">Department of Respiratory Medicine, the Second Affiliated Hospital of Fujian Medical University,  Quanzhou, Fujian Province, China</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2023</Year>
        <Month>07</Month>
        <Day>18</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>08</Month>
        <Day>19</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Asthma, a prevalent chronic airway inflammatory condition, poses a significant health challenge. In this study, we delved into the regulatory mechanisms governing asthma, focusing on Methyltransferase-like 3 (METTL3).
Through an ovalbumin (OVA)-induced mouse model and interleukin-13 (IL-13)-induced cell model, we mimicked the in vivo and in vitro functions of METTL3 in asthma.
Our research revealed that METTL3 expression significantly decreased in asthma-induced mice and IL-13-stimulated cells compared to the control group. Moreover, METTL3 overexpression enhanced bronchial epithelial cell viability and proliferation. Mechanistically, we observed elevated levels of total iron, Fe2+, malondialdehyde (MDA), lipid reactive oxygen species (ROS), alongside reduced glutathione (GSH) levels in IL-13-stimulated cells. Remarkably, METTL3 overexpression counteracted these effects, suggesting a pivotal role in mitigating asthma-related oxidative stress. Furthermore, our study highlighted the involvement of N6-methyladenosine methylation (m6A) modification, where METTL3 regulated the m6A modification of glutathione peroxidase 4 (GPX4) RNA, impacting RNA stability. Knockdown of METTL3 suppressed m6A modification on GPX4 RNA, impairing its stability and contributing to IL-13-induced ferroptosis. Interestingly, METTL3 overexpression not only inhibited cell ferroptosis but also alleviated asthma symptoms.
Our findings shed light on the epigenetic regulation of asthma through METTL3-mediated m6A modification, offering potential therapeutic avenues for this prevalent inflammatory disease.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/3876</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/3876/2007</pdf_url>
  </Article>
</Articles>
